From July 26, 2022 to September 30, 2022, the company has repurchased 6,559,178 shares, representing 1.67% for $557.73 million. With this, the company has completed the repurchase of 6,559,178 shares, representing 1.67% for $557.73 million under the buyback announced on July 28, 2022.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
115.1 USD | -0.80% | -0.81% | -7.32% |
Jun. 20 | Glucotrack Announces the Appointment of Andy Balo to Board of Directors | CI |
Jun. 20 | Dexcom Expands Aid Partnership into the Netherlands | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.32% | 46.16B | |
-3.63% | 185B | |
-1.54% | 105B | |
-2.23% | 68.9B | |
+14.56% | 46.41B | |
+5.36% | 40.75B | |
+20.31% | 31.11B | |
+11.60% | 24.26B | |
-5.77% | 23.94B | |
-12.65% | 21.86B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- Tranche Update on DexCom, Inc.'s Equity Buyback Plan announced on July 28, 2022.